MLH1 polymorphisms and cancer risk: a meta-analysis based on 33 case-control studies.

Abstract

OBJECTIVE Cumulative evidence suggests that MLH1, the key component in the mismatch pathway, plays an important role in human cancers. Two potential functional polymorphisms (-93G>A and I219V) of MLH1 have been implicated in cancer risk. The aim of this meta-analysis was to summarize the evidence for associations. METHODS Eligible studies were identified… (More)

Topics

6 Figures and Tables

Cite this paper

@article{Xu2012MLH1PA, title={MLH1 polymorphisms and cancer risk: a meta-analysis based on 33 case-control studies.}, author={Jia-li Xu and Zhi-qiang Yin and Ming-de Huang and Xie-feng Wang and Wen Gao and Ling-xiang Liu and Rong-sheng Wang and Pu-wen Huang and Yong-mei Yin and Ping Liu and Yong-qian Shu}, journal={Asian Pacific journal of cancer prevention : APJCP}, year={2012}, volume={13 3}, pages={901-7} }